Work

What is the risk of pneumonia associated with adalimumab in a patient with COPD, moderate emphysema, and asthma?

Year: 2026

Type: article

Abstract: No direct evidence for the risk of pneumonia with adalimumab in COPD, emphysema, and asthma, but general data indicates an increased infection risk. Enhanced monitoring and preventive approaches are advised.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.23666166

Author: Tripdatabase

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7223702343

FWCI:

Cites:

Cited by:

Related to: 10